Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/PPO.0000000000000257 http://scihub22266oqcxt.onion/10.1097/PPO.0000000000000257 C5856170!5856170!28410299     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+J 2017 ; 23 (2): 115-24 Nephropedia Template TP {{tp|p=28410299|t=2017. Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies |pdf=|usr=}}{{28410299}} gab.com Text Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies JO: Cancer J http://www.kidney.de/pget.php?&tw=1&pmid=28410299 #FOAvip Historically, immune-based therapies have played a leading role in the treatment of hematologic malignancies, with the efficacy of stem cell transplantation largely attributable to donor immunity against malignant cells. As new and more targeted immunotherapies have developed, their role in the treatment of hematologic malignancies is evolving and expanding. Herein, we discuss approaches for antigen discovery and review known and novel tumor antigens in hematological malignancies. We further explore the role of established and investigational immunotherapies in hematologic malignancies, with a focus on personalization of treatment modalities such as cancer vaccines and adoptive cell therapy. Finally, we identify areas of active investigation and development. Immunotherapy is at an exciting crossroads for the treatment of hematologic malignancies, with further investigation aimed at producing effective, targeted immune therapies that maximize anti-tumor effects while minimizing toxicity. Twit Text FOAVip Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies ????Cancer J http://www.kidney.de/pget.php?&tw=1&pmid=28410299 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28410299 #FOAvip English Wikipedia <ref>{{Cite pmid|28410299}}</ref> Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies #MMPMID28410299 Braun DA; Wu CJ Cancer J 2017[Mar]; 23 (2): 115-24 PMID28410299show ga Historically, immune-based therapies have played a leading role in the treatment of hematologic malignancies, with the efficacy of stem cell transplantation largely attributable to donor immunity against malignant cells. As new and more targeted immunotherapies have developed, their role in the treatment of hematologic malignancies is evolving and expanding. Herein, we discuss approaches for antigen discovery and review known and novel tumor antigens in hematological malignancies. We further explore the role of established and investigational immunotherapies in hematologic malignancies, with a focus on personalization of treatment modalities such as cancer vaccines and adoptive cell therapy. Finally, we identify areas of active investigation and development. Immunotherapy is at an exciting crossroads for the treatment of hematologic malignancies, with further investigation aimed at producing effective, targeted immune therapies that maximize anti-tumor effects while minimizing toxicity. äAntigen Discovery and Therapeutic Targeting in Hematologic Malignancie(epmc).pdf DeepDyve Pubget Overpricing